Large-scale production of CD4+ T cells from HIV-1-infected donors after CD3/CD28 costimulation

Journal of Hematotherapy and Stem Cell Research

Volumn 7, Issue 5, 1998, Pages 437-448

  Levine, Bruce L ^a,b   Cotte, Julio ^a,b   Small, Carolynn C ^a,b   Carroll, Richard G ^a,b   Riley, James L ^c   Bernstein, Wendy B ^c,d   Van Epps, Dennis E ^e   Hardwick, R Alan ^e   June, Carl H ^a,b,d  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d Uniformed Services University of the Health Sciences   (United States)

^e Nexell Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN;

APHERESIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CELL SEPARATION; CENTRIFUGATION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTOPOIESIS; PRIORITY JOURNAL;

EID: 0031737652     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1998.7.437     Document Type: Article

References (39)

1. Rosenberg, S.A., Lotze, M.T., Muul, L.M., et al. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N. Engl. J. Med. 313:1485, 1985.
2. Muul, L.M., Director, E.P., Hyatt, C.L., et al. Large-scale production of human lymphokine activated killer cells for use in adoptive immunotherapy. J. Immunol. Methods 88:265, 1986.
3. Muul, L.M., Nason-Burchenal, K., Carter, C.S., et al. Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy. J. Immunol. Methods 101:171, 1987.
4. Yannelli, J.R. The preparation of effector cells for use in the adoptive cellular immunotherapy of human cancer. J. Immunol. Methods 139:1, 1991.
5. Nakamura, Y., Tokuda, Y., Iwasawa, M., et al. Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumor immunotherapy. Br. J. Cancer 66:20, 1992.
6. Miller, J.S., Klingsporn, S., Lund, J., et al. Large scale ex vivo expansion and activation of human natural killer cells for autologous therapy. Bone Marrow Transplant. 14:555, 1994.
7. Freedman, R.S., Tomasovic, B., Templin, S., et al. Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J. Immunol. Methods 167:145, 1994.
8. Sekine, T., Shiraiwa, H., Yamazaki, T., et al. A feasible method for expansion of peripheral blood lymphocytes by culture with immobilized anti-CD3 monoclonal antibody and interleukin-2 for use in adoptive immunotherapy of cancer patients. Biomed. Pharmacother. 47:73, 1993.
9. Morecki, S., Gelfand, Y., Levi, S., et al. Activated long-term peripheral blood cultures as preparation for adoptive alloreactive cell therapy in cancer patients. J. Hematother. 6:115, 1997.
10. Walter, E.A., Greenberg, P.D., Gilbert, M.J., et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333:1038, 1995.
11. Klimas, N., Patarca, R., Walling, J., et al. Clinical and immunological changes in AIDS patients following adoptive therapy with activated autologous CD8 T cells and interleukin-2 infusion. AIDS 8:1073, 1994.
12. Riddell, S.R., Greenberg, P.D., Overell, R.W., et al. Phase I study of cellular adoptive immunotherapy using genetically identified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. Hum. Gene Ther. 3:319, 1992.
13. Riddell, S.R., Elliott, M., Lewinsohn, D.A., et al. T-cell-mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 2:216, 1996.
14. Lieberman, J., Skolnik, P.R. Parkerson, G.R., 3rd, et al. Safety of autologous, ex vivo-expanded human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte infusion in HIV-infected patients. Blood 90:2196, 1997.
15. Walker, R., Blaese, R.M., Carter, C.S., et al. A study of the safety and survival of the adoptive transfer of genetically marked syngeneic lymphocytes in HIV-infected identical twins. Hum. Gene Ther. 4:659, 1993.
16. Bex, F., Hermans, P., Sprecher, S., et al. Syngeneic adoptive transfer of anti-human immunodeficiency virus-1 (HIV-1)-primed lymphocytes from a vaccinated HIV-seronegative individual to his HIV-1-infected identical twin. Blood 84:3317, 1994.
17. Autran, B., Carcelain, G., Li, T.S., et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112, 1997.
18. Gulick, R.M., Mellors, J.W., Havlir, D., et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N. Engl. J. Med. 337:734, 1997.
19. Hammer, S.M., Squires, K.E., Hughes, M.D., et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N. Engl. J. Med. 337:725, 1997.
20. Fauci, A.S. Host factor and the pathogenesis of HIV-induced diseases. Nature 384:529, 1996.
21. Finzi, D., Hermankova, M., Pierson, T., et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295, 1997.
22. Chun, T.W., Stuyver, L., Mizell, S.B., et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94:13193, 1997.
23. Wong, J.K., Hezareh, M., Gunthard, H.F., et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291, 1997.
24. Wilson, C.C., Wong, J.T., Girard, D.D., et al. Ex vivo expansion of CD4 lymphocytes from human immunodeficiency virus type 1-infected persons in the presence of combination antiretroviral agents. J. Infect. Dis. 172:88, 1995.
25. Levine, B.L., Bernstein, W.B., Connors, M., et al. Effects of CD28 costimulation on long-term proliferation of CD44-T cells in the absence of exogenous feeder cells. J. Immunol. 159:5921, 1997.
26. Levine, B.L., Ueda, Y., Craighead, N., et al. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro. Int. Immunol. 7:891, 1995.
27. Levine, B.L., Mosca, J.D., Riley, J.L., et al. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 272:1939, 1996.
28. Carroll, R.G., Riley, J.L., Levine, B.L., et al. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. Science 276:273, 1997.
29. Riley, J.L., Carroll, R.G., Levine, B.L., et al. Intrinsic resistance to T cell infection with HIV type 1 induced by CD28 costimulation. J. Immunol. 158:5545, 1997.
30. Rollins, B.J. Chemokines. Blood 90:909, 1997.
31. Cocchi, F., DeVico, A.L., Garzino-Demo, A., et al. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811, 1995.
32. June, C.H., Ledbetter, J.A., Gillespie, M.M., et al. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell Biol. 7:4472, 1987.
33. Vahey, M.T., & Wong, M.T. Quantitative liquid hybridization PCR method employing storage phosphor technology. In PCR Primer: A Laboratory Manual, eds. Dieffenbach, C.W. & Dveksler, G.S. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1995, p. 313.
34. Greenberg, S., & Silverstein, S.C. Phagocytosis. In Fundamental Immunology, 3rd ed., ed. Paul, W.E. Raven Press, Ltd. New York, 1993, p. 941.
35. Hardwick, R.A., Prisco, M.R. & Shah, D.O. A large-scale magnetic separator for selective cell separations with paramagnetic microbeads. Artif. Organs 14:342, 1990.
36. Pantaleo, G. How immune-based interventions can change HIV therapy. Nat. Med. 3:483, 1997.
37. Rowland-Jones, S. & Tan, R. Control of HIV co-receptor expression: Implications for pathogenesis and treatment. Trends Microbiol. 5:300, 1997.
38. Bunnell, B.A., Metzger, M., Byrne, E., et al. Efficient in vivo marking of primary CD4+ T lymphocytes in nonhuman primates using a gibbon ape leukemia virus-derived retroviral vector. Blood 89:1987, 1997.
39. Hardwick, R.A., Kulcinski, D., Mansour, V., et al. Design of large-scale separation systems for positive and negative immunomagnetic selection of cells using superparamagnetic microspheres. J. Hematother. 1:379, 1992.